Compound 1653
Identifiers
- Canonical SMILES:
COc1cc(CNCCO)cc(Cl)c1OCc1ccc(Cl)cc1Cl
- IUPAC name:
2-[({3-chloro-4-[(2,4-dichlorophenyl)methoxy]-5-methoxyphenyl}methyl)amino]ethanol - InChi:
InChI=1S/C17H18Cl3NO3/c1-23-16-7-11(9-21-4-5-22)6-15(20)17(16)24-10-12-2-3-13(18)8-14(12)19/h2-3,6-8,21-22H,4-5,9-10H2,1H3
- InChiKey:
GZFBOMZAQBAFPC-UHFFFAOYSA-N
External links
![]() 2200697 |
![]() CHEMBL1624864 |
External search
|
|
|
|
|
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 1 | 0 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|---|---|---|
| NRP / VEGF | 5.14 | cancer | Inhibition |
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 389.04 g/mol | |||
| HBA | 4 | |||
| HBD | 2 | |||
| HBA + HBD | 6 | |||
| AlogP | 4.06 | |||
| TPSA | 50.72 | |||
| RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 |
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.4821 | Safinamide | DB06654 | |
| 0.4775 | Itopride | DB04924 | |
| 0.4690 | Priralfinamide | DB06649 | |
| 0.4688 | Fipexide | DB13790 | |
| 0.4628 | N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE | DB08610 | |
| 0.4609 | Trimethobenzamide | DB00662 | |
| 0.4466 | Etamivan | DB08989 | |
| 0.4444 | Trimetazidine | DB09069 | |
| 0.4433 | Bephenium | DB13462 | |
| 0.4419 | 4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE | DB08072 | |
| 0.4352 | Bupranolol | DB08808 | |
| 0.4252 | Pinaverium | DB09090 | |
| 0.4206 | Bitolterol | DB00901 | |
| 0.4206 | Phenoxybenzamine | DB00925 | |
| 0.4133 | N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE | DB06859 |




